Voyager Therapeutics Inc. (VYGR)
NASDAQ · Healthcare
Voyager Therapeutics Inc. Operating Income 2015–2025
Voyager Therapeutics Inc. annual/quarterly operating income history and growth rate from 2015 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Voyager Therapeutics Inc. operating income for the quarter ending March 31, 2026 was -30.3 M, a 12.75% decrease year-over-year.
- Voyager Therapeutics Inc. operating income for the twelve months ending March 31, 2026 was -132.2 M, a 77.44% increase year-over-year.
- Voyager Therapeutics Inc. annual operating income for 2025 was -131.8 M, a 58.30% increase from 2024.
- Voyager Therapeutics Inc. annual operating income for 2024 was -83.3 M, a 168.26% decrease from 2023.
- Voyager Therapeutics Inc. annual operating income for 2023 was 122.0 M, a 340.01% decrease from 2022.
- Voyager Therapeutics Inc. annual operating income for 2022 was -50.8 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Voyager Therapeutics Inc. Operating Income — FAQ
Voyager Therapeutics Inc. (VYGR) operating income over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
What is Voyager Therapeutics Inc.'s operating income?
Voyager Therapeutics Inc. (VYGR) reported operating income of -$132M for fiscal 2025.
Where can I see VYGR's operating income history?
The chart and table above show Voyager Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.